NeuroBlate System
Monteris Medical · Decision date Sep 3, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 3, 2026 for the NeuroBlate System, submitted by Monteris Medical of Minnetonka, Minnesota, under 510(k) number K262315. The application was received July 8, 2026 and reviewed as a traditional 510(k) by the Neurology panel, with regulation number 878.4810, Class II, product code ONO, and a regulation medical specialty listed as General and Plastic Surgery. SESE denotes 510(k) clearance, not premarket approval.
The submission describes no physical changes to the NeuroBlate hardware, software, accessories, operating principles or functionality; the stated change is an indication clarification in the instructions for use. The system is described as MRI-compatible laser delivery probes, a robotic probe driver, an interface platform, electronics rack and a control workstation with M-Vision software. The summary lists K260976 and K240877 as predicates and K214125 as a reference predicate. The summary text does not establish clinical performance for the clarified labeling, and no independent evaluation of the clarification is included in the provided material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262315
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Monteris Medical
- Product code
- ONO
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Neurosurgical Laser With Mr Thermography.
- Applicant
- Monteris Medical
- Product code
- ONO
- FDA device class
- 2
FDA decision timeline
K262315 received
Application receipt date recorded by FDA.
K262315 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Monteris Medical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Minnetonka, MN
Sources and methodology
- Original FDA record: K262315
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records